Neurogene (NGNE) Tops Q2 EPS by 38c

Neurogene (NASDAQ: NGNE) reported Q2 EPS of ($1.05), $0.38 better than the analyst estimate of ($1.43).

For earnings history and earnings-related data on Neurogene (NGNE) click here.

You May Also Be Interested In

• Robinhood Ventures Fund II opens at $22.50, IPO at $25
• SuperCom (SPCB) Tops Q3 EPS by 43c
• Tencent Holdings (700:HK) (TCEHY) PT Lowered to HK$625 at Benchmark to Reflect Downward Earnings Revisions